www.humira.com
Open in
urlscan Pro
2600:9000:2127:c200:5:8ced:94c0:93a1
Public Scan
Submitted URL: http://citrate-free-humira.com/
Effective URL: https://www.humira.com/citrate-free
Submission: On December 16 via api from TR — Scanned from DE
Effective URL: https://www.humira.com/citrate-free
Submission: On December 16 via api from TR — Scanned from DE
Form analysis 0 forms found in the DOM
Text Content
Health insurance coverage changing? Call 1.800.4HUMIRA or click to see how we
can help ▸
Skip to Main content
* Choose Condition
* Moderate to Severe Rheumatoid Arthritis
* Moderate to Severe Chronic Plaque Psoriasis
* Moderate to Severe Crohn's Disease
* Moderate to Severe Pediatric Crohn's Disease
* Moderate to Severe Ulcerative Colitis
* Moderate to Severe Pediatric Ulcerative Colitis
* Psoriatic Arthritis
* Moderate to Severe Hidradenitis Suppurativa
* Ankylosing Spondylitis
* Moderate to Severe Polyarticular Juvenile Idiopathic Arthritis
* Non-Infectious Intermediate, Posterior, and Panuveitis
* Important Safety Information
* Full Prescribing Information & Patient Information
* Full Prescribing Information (English)
* Full Prescribing Information (En Español)
* Medication Guide
* Health Care Professionals
Cost & Savings
* Cost & Savings
* Log In or Sign Up
*
* logout
* Humira Complete
* Home
* LEARN ABOUT HUMIRA
* Moderate to Severe Rheumatoid Arthritis
* Moderate to Severe Chronic Plaque Psoriasis
* Moderate to Severe Crohn's Disease
* Moderate to Severe Pediatric Crohn's Disease
* Moderate to Severe Ulcerative Colitis
* Moderate to Severe Pediatric Ulcerative Colitis
* Psoriatic Arthritis
* Moderate to Severe Hidradenitis Suppurativa
* Ankylosing Spondylitis
* Moderate to Severe Polyarticular Juvenile Idiopathic Arthritis
* Non-Infectious Intermediate, Posterior, and Panuveitis
* Additional Safety Information
* STARTING HUMIRA
* About HUMIRA Complete
* Resources for You
* Save on HUMIRA
* Check Your Insurance Coverage
* Insurance Explained
* Your HUMIRA Ambassador
* How to Inject HUMIRA
* Sign Up for HUMIRA Complete
* HUMIRA COMPLETE RESOURCES
* Complete Resource Center
* Log In or Sign Up
* HUMIRA and Your Routine
* COST AND LOGIN
* Cost & Savings
* Log In or Sign Up
ON THIS PAGE:
Packaging information
Frequently asked questions
Dosing information
WHAT IS HUMIRA CITRATE-FREE?
HUMIRA Citrate-free works the same as original HUMIRA, but with less pain
immediately following injection.* The active ingredient (adalimumab) is the same
as it has been for over 15 years.
If you are interested in getting started with HUMIRA Citrate-free, ask your
doctor for about a prescription.
*Compared to HUMIRA 40 mg/0.8 mL.
ALREADY TAKING ORIGINAL HUMIRA AND READY TO TRANSITION TO HUMIRA CITRATE-FREE?
If you and your doctor decide together that HUMIRA Citrate-free is right for
you, you will need to start a new prescription. You will not be automatically
transitioned to HUMIRA Citrate-free.
HUMIRA Citrate-free comes in both the HUMIRA Pen and prefilled syringe, and is
injected the same way as original HUMIRA.
Ask your doctor about a new prescription when you are ready for your next HUMIRA
refill.
HUMIRA CITRATE-FREE PACKAGING
Packaging for HUMIRA Citrate-free may vary depending on the inventory of your
specialty pharmacy. The easiest way to tell the difference between original
HUMIRA and HUMIRA Citrate-free is to look for the 29-gauge needle call-out on
the front of the package. In addition, the packaging for your starting dose of
HUMIRA Citrate-free may look different from the packaging for your maintenance
dose.
For more information about the HUMIRA Citrate-free packaging, call 1.800.4HUMIRA
(1.800.448.6472).
GET TO KNOW HUMIRA CITRATE-FREE
CHANGES YOU CAN’T SEE
Less pain, same HUMIRA
* HUMIRA Citrate-free is less painful immediately following injection,*but
works just like original HUMIRA.
* Citrate buffers associated with injection pain were removed.
* The active ingredient (adalimumab) is the same as it has been for over 15
years
Needle cover
* The needle cover for the HUMIRA Citrate-free Pen and prefilled syringe is not
made with natural rubber latex
*Compared to HUMIRA 40 mg/0.8 mL.
CHANGES YOU CAN SEE
Updated box
* Packaging for HUMIRA Citrate-free may vary depending on the inventory of your
specialty pharmacy. Look for the 29-gauge needle call-out on the front of the
box.
Thinner needle
* Look for the “29-gauge needle” call-out on your HUMIRA Citrate-free box
Less liquid
* HUMIRA Citrate-free contains less liquid with the same amount of active
ingredient (adalimumab)
Redesigned Pen
* The numbers on the caps are now white, and the HUMIRA Pen has a larger
viewing window
HUMIRA CITRATE-FREE ALSO COMES IN A PREFILLED SYRINGE. ASK YOUR DOCTOR ABOUT A
NEW PRESCRIPTION FOR HUMIRA CITRATE-FREE.
FREQUENTLY ASKED QUESTIONS
What is HUMIRA Citrate-free?
HUMIRA Citrate-free is the same as original HUMIRA, but without citrate .
buffers, and includes other device enhancements. The latest HUMIRA presentation,
Citrate-free, works just like original HUMIRA, but with less pain immediately
following injection.* The active ingredient (adalimumab) is the same as it has
been for over 15 years.
Other enhancements include a thinner needle and 50% less liquid to inject
compared to original HUMIRA. The HUMIRA Pen has also been enhanced to include a
larger viewing window and white numbers on the caps. And, the black needle cover
is not made with natural rubber latex. HUMIRA Citrate-free comes in the HUMIRA
Pen and the prefilled syringe.
If you are interested in taking HUMIRA Citrate-free, ask your doctor for about a
prescription before your next HUMIRA refill.
*Compared to HUMIRA 40 mg/0.8 mL.
Do I need a new prescription for HUMIRA Citrate-free?
Yes, your doctor will need to write you a prescription for HUMIRA Citrate-free
whether you are just starting treatment with HUMIRA or have been taking original
HUMIRA for some time. You may need to finish your current HUMIRA prescription
before you can start HUMIRA Citrate-free.
If you and your doctor decide HUMIRA Citrate-free is right for you, a new prior
authorization (PA) may be required depending on your insurance. A PA is a common
requirement when refilling a prescription for another year or just starting a
prescription for a chronic condition. However, your insurance may not cover
HUMIRA Citrate-free until you are due for a refill.
If you have questions about your HUMIRA, call 1.800.4HUMIRA (1.800.448.6472).
If I’m already taking HUMIRA, will I be automatically transitioned to HUMIRA
Citrate-free?
No, you will not automatically be transitioned to HUMIRA Citrate-free. Talk to
your doctor about HUMIRA Citrate-free, and decide together on the best treatment
for you.
Once your doctor has written a new prescription for HUMIRA Citrate-free, you may
call your specialty pharmacy to ensure they are aware of the change prior to
your next refill.
How will I know if I’ve received HUMIRA Citrate-free?
To be sure you’ve received HUMIRA Citrate-free, look for a 29-gauge needle
call-out on the front of your product’s packaging, along with white numbers
located on the caps of the HUMIRA Pen.
Packaging for HUMIRA Citrate-free may vary, depending on the inventory of your
specialty pharmacy. In addition, packaging for the starting dose of HUMIRA
Citrate-free may look different than the packaging for the maintenance dose.
If you are unsure about the HUMIRA you have received, call 1.800.4HUMIRA
(1.800.448.6472).
Is HUMIRA Citrate-free available in both the Pen and prefilled syringe?
Yes, HUMIRA Citrate-free is available in both the Pen and prefilled syringe.
The HUMIRA Citrate-free Pen is similar to the Pen for original HUMIRA; however,
HUMIRA Citrate-free also features enhancements such as a thinner needle, a
larger viewing window, and white numbers on caps. The black needle cover of the
Citrate-free Pen is and prefilled syringe are not made with natural rubber
latex.
Both the Pen and prefilled syringe feature a 29-gauge needle call-out on the
front of the box. If you are unsure about the HUMIRA you have received, call
1.800.4HUMIRA (1.800.448.6472).
If I’m already taking HUMIRA, will my insurance cover HUMIRA Citrate-free?
If your insurance currently covers HUMIRA, it will likely may also cover HUMIRA
Citrate-free. However, depending on your insurance plan, a new prior
authorization (PA) may be required. Your insurance may also require you to
finish your current supply before you can start a new prescription for HUMIRA
Citrate-free.
If you are already on original HUMIRA or just getting started with HUMIRA
Citrate-free and have questions about your insurance coverage, connect with an
Insurance Specialist by calling 1.800.4HUMIRA (1.800.448.6472).
Are there any changes to the storage requirements for HUMIRA Citrate-free?
There are no changes to the storage and handling requirements of HUMIRA. HUMIRA
Citrate-free can be stored at room temperature for up to 14 days. If not used
within that time, it should be discarded.
View additional Frequently Asked Questions about HUMIRA
HUMIRA CITRATE-FREE DOSING INFORMATION FOR ADULT INDICATIONS
It’s important to use the proper injection technique and follow the dosing
schedule for your treatment with HUMIRA Citrate-free.
Moderate to Severe Rheumatoid Arthritis
The recommended dose is 1 HUMIRA Pen or syringe (40 mg/0.4 mL) every other week.
Always follow your doctor's instructions about when and how often to take HUMIRA
Citrate-free.
For more information, refer to the Patient Instructions for Use, and the
Medication Guide located inside your HUMIRA Citrate-free carton, and within the
Full Prescribing Information.
If you have any questions about injection, you can speak to a registered nurse
about your HUMIRA treatment and request in-person injection training. Just call
1.800.4HUMIRA (1.800.448.6472).
Starting HUMIRA Citrate-free
Make sure you have been shown how to inject HUMIRA Citrate-free before you do it
yourself. Your first injection should be given under the supervision of a health
care professional. Remember to keep your HUMIRA Citrate-free refrigerated in its
original container until ready for use.
YOU WILL INJECT 1 HUMIRA PEN
40 mg/0.4 mL Pen
Or
80 mg/0.8 mL Pen
Note: 40 mg/0.4 mL and 80 mg/0.8 mL are each also available in a prefilled
syringe.
Continue taking HUMIRA Citrate-free as directed by your doctor. Remember, HUMIRA
Citrate-free is a treatment, not a cure. Your doctor can tell you if and when
you should stop taking HUMIRA Citrate-free.
If you experience any adverse reactions or discomfort when taking HUMIRA
Citrate-free, discuss them with your doctor right away.
Common side effects of HUMIRA include injection site reactions (pain, redness,
rash, swelling, itching, or bruising), upper respiratory infections (sinus
infections), headaches, rash, and nausea. These are not all of the possible side
effects with HUMIRA. Tell your doctor if you have any side effect that bothers
you or does not go away.
Read About the Important Safety Information for HUMIRA
HUMIRA Use1
HUMIRA is a prescription medicine used alone, with methotrexate, or with certain
other medicines to reduce the signs and symptoms of moderate to severe
rheumatoid arthritis in adults, may prevent further damage to your bones and
joints, and may help your ability to perform daily activities.
Moderate to Severe Chronic Plaque Psoriasis
The chart below explains a standard HUMIRA Citrate-free dosing schedule. Always
follow your doctor's instructions about when and how often to take HUMIRA
Citrate-free.
For more information, refer to the Patient Instructions for Use, and the
Medication Guide located inside your HUMIRA Citrate-free carton, and within the
Full Prescribing Information.
If you have any questions about injection, you can speak to a registered nurse
about your HUMIRA treatment and request in-person injection training. Just
call 1.800.4HUMIRA (1.800.448.6472).
Starting HUMIRA Citrate-free
Important: You must pay attention to your starting dose—it is different than
your maintenance dose and is a critical part of taking HUMIRA Citrate-free as
prescribed. Make sure you have been shown how to inject HUMIRA Citrate-free
before you do it yourself. Your first injection should be given under the
supervision of a health care professional. Remember to keep your HUMIRA
Citrate-free refrigerated in its original container until ready for use.
STARTING DOSE DAY 1
1 HUMIRA Pen (80 mg/0.8 mL)
STARTING DOSE DAY 8
1 HUMIRA Pen (40 mg/0.4 mL)
CONTINUING DOSE DAY 22
and every other week thereafter
1 HUMIRA Pen (40 mg/0.4 mL)
On Day 22 you will begin your regularly scheduled dose of 1 HUMIRA Pen (40
mg/0.4 mL) every other week.
Note: 40 mg/0.4 mL is also available in a prefilled syringe.
Continue taking HUMIRA Citrate-free as directed by your doctor. Remember, HUMIRA
Citrate-free is a treatment, not a cure. Your doctor can tell you if and when
you should stop taking HUMIRA Citrate-free.
If you experience any adverse reactions or discomfort when taking HUMIRA
Citrate-free, discuss them with your doctor right away.
Common side effects of HUMIRA include injection site reactions (pain, redness,
rash, swelling, itching, or bruising), upper respiratory infections (sinus
infections), headaches, rash, and nausea. These are not all of the possible side
effects with HUMIRA. Tell your doctor if you have any side effect that bothers
you or does not go away.
Read About the Important Safety Information for HUMIRA
HUMIRA Use1
HUMIRA is a prescription medicine used to treat adults with moderate to severe
chronic plaque psoriasis who are ready for systemic therapy or phototherapy, and
are under the care of a doctor who will decide if other systemic therapies are
less appropriate.
Moderate to Severe Crohn’s Disease
The chart below explains a standard HUMIRA Citrate-free dosing schedule. Always
follow your doctor's instructions about when and how often to take HUMIRA
Citrate-free.
For more information, refer to the Patient Instructions for Use, and
the Medication Guide located inside your HUMIRA Citrate-free carton, and within
the Full Prescribing Information.
If you have any questions about injection, you can speak to a registered nurse
about your HUMIRA treatment and request in-person injection training. Just
call 1.800.4HUMIRA (1.800.448.6472).
Starting HUMIRA Citrate-free
Important: You must pay attention to your starting dose—it is different than
your maintenance dose and is a critical part of taking HUMIRA Citrate-free as
prescribed. Make sure you have been shown how to inject HUMIRA Citrate-free
before you do it yourself. Your first injection should be given under the
supervision of a health care professional. Remember to keep your HUMIRA
Citrate-free refrigerated in its original container until ready for use.
STARTING DOSE DAY 1*
2 HUMIRA 80 mg/0.8 mL Pens (160 mg)
STARTING DOSE DAY 15
1 HUMIRA Pen (80 mg/0.8 mL)
CONTINUING DOSE DAY 29
and every other week thereafter
1 HUMIRA Pen (40 mg/0.4 mL)
*First dose can be administered as 2 injections in 1 day or as 1 injection per
day for 2 consecutive days.
On Day 29 you will begin your regularly scheduled dose of 1 HUMIRA Pen (40
mg/0.4 mL) every other week.
Note: 40 mg/0.4 mL is also available in a prefilled syringe.
Continue taking HUMIRA Citrate-free as directed by your doctor. Remember, HUMIRA
Citrate-free is a treatment, not a cure. Your doctor can tell you if and when
you should stop taking HUMIRA Citrate-free.
If you experience any adverse reactions or discomfort when taking HUMIRA
Citrate-free, discuss them with your doctor right away.
Common side effects of HUMIRA include injection site reactions (pain, redness,
rash, swelling, itching, or bruising), upper respiratory infections (sinus
infections), headaches, rash, and nausea. These are not all of the possible side
effects with HUMIRA. Tell your doctor if you have any side effect that bothers
you or does not go away.
Read About the Important Safety Information for HUMIRA
HUMIRA Use1
HUMIRA is a prescription medicine used to reduce signs and symptoms, and to
achieve and maintain clinical remission in adults with moderate to severe
Crohn’s disease who have not responded well to certain other medications. HUMIRA
is also used to reduce signs and symptoms and achieve clinical remission in
these adults who have also lost response to or are unable to tolerate
infliximab.
Moderate to Severe Ulcerative Colitis
The chart below explains a standard HUMIRA Citrate-free dosing schedule. Always
follow your doctor's instructions about when and how often to take HUMIRA
Citrate-free.
For more information, refer to the Patient Instructions for Use, and
the Medication Guide located inside your HUMIRA Citrate-free carton, and within
the Full Prescribing Information.
If you have any questions about injection, you can speak to a registered nurse
about your HUMIRA treatment and request in-person injection training. Just
call 1.800.4HUMIRA (1.800.448.6472).
STARTING HUMIRA CITRATE-FREE
Important: You must pay attention to your starting dose—it is different than
your maintenance dose and is a critical part of taking HUMIRA Citrate-free as
prescribed. Make sure you have been shown how to inject HUMIRA Citrate-free
before you do it yourself. Your first injection should be given under the
supervision of a health care professional. Remember to keep your HUMIRA
Citrate-free refrigerated in its original container until ready for use.
STARTING DOSE DAY 1*
2 HUMIRA 80 mg/0.8 mL Pens (160 mg)
STARTING DOSE DAY 15
1 HUMIRA Pen (80 mg/0.8 mL)
CONTINUING DOSE DAY 29
and every other week thereafter
1 HUMIRA Pen (40 mg/0.4 mL)
*First dose can be administered as 2 injections in 1 day or as 1 injection per
day for 2 consecutive days.
On Day 29 you will begin your regularly scheduled dose of 1 HUMIRA Pen (40
mg/0.4 mL) every other week.
Note: 40 mg/0.4 mL is also available in a prefilled syringe.
Continue taking HUMIRA Citrate-free as directed by your doctor. Remember, HUMIRA
Citrate-free is a treatment, not a cure. Your doctor can tell you if and when
you should stop taking HUMIRA Citrate-free.
If you experience any adverse reactions or discomfort when taking HUMIRA
Citrate-free, discuss them with your doctor right away.
Common side effects of HUMIRA include injection site reactions (pain, redness,
rash, swelling, itching, or bruising), upper respiratory infections (sinus
infections), headaches, rash, and nausea. These are not all of the possible side
effects with HUMIRA. Tell your doctor if you have any side effect that bothers
you or does not go away.
Read About the Important Safety Information for HUMIRA
HUMIRA Use1
HUMIRA is a prescription medicine used in adults to help get moderate to severe
ulcerative colitis under control (induce remission) and keep it under control
(sustain remission) when certain other medicines have not worked well enough. It
is not known if HUMIRA is effective in people who stopped responding to or could
not tolerate anti-TNF medicines.
Psoriatic Arthritis
The recommended dose is 1 HUMIRA Pen or syringe (40 mg/0.4 mL) every other week.
Always follow your doctor's instructions about when and how often to take HUMIRA
Citrate-free.
For more information, refer to the Patient Instructions for Use, and
the Medication Guide located inside your HUMIRA Citrate-free carton, and within
the Full Prescribing Information.
If you have any questions about injection, you can speak to a registered nurse
about your HUMIRA treatment and request in-person injection training. Just
call 1.800.4HUMIRA (1.800.448.6472).
Starting HUMIRA Citrate-free
Make sure you have been shown how to inject HUMIRA Citrate-free before you do it
yourself. Your first injection should be given under the supervision of a health
care professional. Remember to keep your HUMIRA Citrate-free refrigerated in its
original container until ready for use.
Note: 40 mg/0.4 mL is also available in a prefilled syringe.
YOU WILL INJECT 1 HUMIRA PEN
40 mg/0.4 mL Pen
Continue taking HUMIRA Citrate-free as directed by your doctor. Remember, HUMIRA
Citrate-free is a treatment, not a cure. Your doctor can tell you if and when
you should stop taking HUMIRA Citrate-free.
If you experience any adverse reactions or discomfort when taking HUMIRA
Citrate-free, discuss them with your doctor right away.
Common side effects of HUMIRA include injection site reactions (pain, redness,
rash, swelling, itching, or bruising), upper respiratory infections (sinus
infections), headaches, rash, and nausea. These are not all of the possible side
effects with HUMIRA. Tell your doctor if you have any side effect that bothers
you or does not go away.
Read About the Important Safety Information for HUMIRA
HUMIRA Use1
HUMIRA is a prescription medicine used alone or with certain other medicines to
reduce the signs and symptoms of psoriatic arthritis in adults, may prevent
further damage to your bones and joints, and may help your ability to perform
daily activities.
Moderate to Severe Hidradenitis Suppurativa
The chart below explains a standard HUMIRA Citrate-free dosing schedule. Always
follow your doctor's instructions about when and how often to take HUMIRA
Citrate-free.
For more information, refer to the Patient Instructions for Use, and
the Medication Guide located inside your HUMIRA Citrate-free carton, and within
the Full Prescribing Information.
If you have any questions about injection, you can speak to a registered nurse
about your HUMIRA treatment and request in-person injection training. Just
call 1.800.4HUMIRA (1.800.448.6472).
Starting HUMIRA Citrate-free
Important: You must pay attention to your starting dose—it is different than
your maintenance dose and is a critical part of taking HUMIRA Citrate-free as
prescribed. Make sure you have been shown how to inject HUMIRA Citrate-free
before you do it yourself. Your first injection should be given under the
supervision of a health care professional. Remember to keep your HUMIRA
Citrate-free refrigerated in its original container until ready for use.
STARTING DOSE DAY 1*
2 HUMIRA 80 mg/0.8 mL Pens (160 mg)
STARTING DOSE DAY 15
1 HUMIRA Pen (80 mg/0.8 mL)
CONTINUING DOSE DAY 29
Begin 40 mg every week or 80 mg every other week dosing there after
1 HUMIRA Pen (40 mg/0.4 mL)
Or
1 HUMIRA Pen (80 mg/0.8 mL)
*First dose can be administered as 2 injections in 1 day or as 1 injection per
day for 2 consecutive days.
On Day 29 you will begin your regularly scheduled dose of 1 HUMIRA Pen (40
mg/0.4 mL) every other week.
Note: 40 mg/0.4 mL is also available in a prefilled syringe.
Continue taking HUMIRA Citrate-free as directed by your doctor. Remember, HUMIRA
Citrate-free is a treatment, not a cure. Your doctor can tell you if and when
you should stop taking HUMIRA Citrate-free.
If you experience any adverse reactions or discomfort when taking HUMIRA
Citrate-free, discuss them with your doctor right away.
Common side effects of HUMIRA include injection site reactions (pain, redness,
rash, swelling, itching, or bruising), upper respiratory infections (sinus
infections), headaches, rash, and nausea. These are not all of the possible side
effects with HUMIRA. Tell your doctor if you have any side effect that bothers
you or does not go away.
Read About the Important Safety Information for HUMIRA
HUMIRA Use1
HUMIRA is a prescription medicine used to reduce the signs and symptoms of
moderate to severe hidradenitis suppurativa in people 12 years and older.
Ankylosing Spondylitis
The recommended dose is 1 HUMIRA Pen or syringe (40 mg/0.4 mL) every other week.
Always follow your doctor's instructions about when and how often to take HUMIRA
Citrate-free.
For more information, refer to the Patient Instructions for Use, and the
Medication Guide located inside your HUMIRA Citrate-free carton, and within the
Full Prescribing Information.
If you have any questions about injection, you can speak to a registered nurse
about your HUMIRA treatment and request in-person injection training. Just call
1.800.4HUMIRA (1.800.448.6472).
Starting HUMIRA Citrate-free
Make sure you have been shown how to inject HUMIRA Citrate-free before you do it
yourself. Your first injection should be given under the supervision of a health
care professional. Remember to keep your HUMIRA Citrate-free refrigerated in its
original container until ready for use.
YOU WILL INJECT 1 HUMIRA PEN
40 mg/0.4 mL Pen
Note: 40 mg/0.4 mL is also available in a prefilled syringe.
Continue taking HUMIRA Citrate-free as directed by your doctor. Remember, HUMIRA
Citrate-free is a treatment, not a cure. Your doctor can tell you if and when
you should stop taking HUMIRA Citrate-free.
If you experience any adverse reactions or discomfort when taking HUMIRA
Citrate-free, discuss them with your doctor right away.
Common side effects of HUMIRA include injection site reactions (pain, redness,
rash, swelling, itching, or bruising), upper respiratory infections (sinus
infections), headaches, rash, and nausea. These are not all of the possible side
effects with HUMIRA. Tell your doctor if you have any side effect that bothers
you or does not go away.
Read About the Important Safety Information for HUMIRA
HUMIRA Use1
HUMIRA is a prescription medicine used to reduce the signs and symptoms of
ankylosing spondylitis in adults.
Non-Infectious Intermediate, Posterior, and Panuveitis
The chart below explains a standard HUMIRA Citrate-free dosing schedule. Always
follow your doctor's instructions about when and how often to take HUMIRA
Citrate-free.
For more information, refer to the Patient Instructions for Use, and
the Medication Guide located inside your HUMIRA Citrate-free carton, and within
the Full Prescribing Information.
If you have any questions about injection, you can speak to a registered nurse
about your HUMIRA treatment and request in-person injection training. Just
call 1.800.4HUMIRA (1.800.448.6472).
Starting HUMIRA Citrate-free
Important: You must pay attention to your starting dose—it is different than
your maintenance dose and is a critical part of taking HUMIRA Citrate-free as
prescribed. Make sure you have been shown how to inject HUMIRA Citrate-free
before you do it yourself. Your first injection should be given under the
supervision of a health care professional. Remember to keep your HUMIRA
Citrate-free refrigerated in its original container until ready for use.
STARTING DOSE DAY 1
1 HUMIRA Pen (80 mg/0.8 mL)
STARTING DOSE DAY 8
1 HUMIRA Pen (40 mg/0.4 mL)
CONTINUING DOSE DAY 22
and every other week thereafter
1 HUMIRA Pen (40 mg/0.4 mL)
On Day 22 you will begin your regularly scheduled dose of 1 HUMIRA Pen (40
mg/0.4 mL) every other week.
Note: 40 mg/0.4 mL is also available in a prefilled syringe.
Continue taking HUMIRA Citrate-free as directed by your doctor. Remember, HUMIRA
Citrate-free is a treatment, not a cure. Your doctor can tell you if and when
you should stop taking HUMIRA Citrate-free.
If you experience any adverse reactions or discomfort when taking HUMIRA
Citrate-free, discuss them with your doctor right away.
Common side effects of HUMIRA include injection site reactions (pain, redness,
rash, swelling, itching, or bruising), upper respiratory infections (sinus
infections), headaches, rash, and nausea. These are not all of the possible side
effects with HUMIRA. Tell your doctor if you have any side effect that bothers
you or does not go away.
Read About the Important Safety Information for HUMIRA
HUMIRA Use1
HUMIRA is a prescription medicine used to treat non-infectious intermediate
(middle part of the eye), posterior (back of the eye), and panuveitis (all parts
of the eye) in adults and children 2 years of age and older.
HUMIRA CITRATE-FREE USE IN PEDIATRICS
Moderate to Severe Pediatric Ulcerative Colitis
Moderate to Severe Pediatric Crohn’s Disease
Moderate to Severe Juvenile Idiopathic Arthritis
Moderate to Severe Hidradenitis Suppurativa in Adolescents (12 years and older)
Non-Infectious Intermediate, Posterior, and Panuveitis
HUMIRA COMPLETE IS HERE FOR YOU
Be sure to take advantage of all the other HUMIRA Complete resources available
to you, including:
* Help finding ways to save on the cost of HUMIRA, month after month, with the
HUMIRA Complete Savings Card*
* Assistance with further injection training over the phone, online, and/or in
person
* Access to Insurance Specialists who can help you navigate the insurance
process
Before your next refill, ask your doctor about transitioning to HUMIRA
Citrate-free.
*Eligibility: Available to patients with commercial insurance coverage for
HUMIRA® (adalimumab) who meet eligibility criteria. This co-pay assistance
program is not available to patients receiving prescription reimbursement under
any federal, state, or government-funded insurance programs (for example,
Medicare [including Part D], Medicare Advantage, Medigap, Medicaid, TRICARE,
Department of Defense, or Veterans Affairs programs) or where prohibited by law.
Offer subject to change or termination without notice. Restrictions, including
monthly maximums, may apply. This is not health insurance. For full Terms and
Conditions, visit HUMIRASavingsCard.com or call 1.800.4HUMIRA for additional
information. To learn about AbbVie’s privacy practices and your privacy choices,
visit https://privacy.abbvie
Learn more about HUMIRA Complete
BACK TO TOP
IMPORTANT SAFETY INFORMATION
ABOUT HUMIRA® (ADALIMUMAB)1
WHAT IS THE MOST IMPORTANT INFORMATION I SHOULD KNOW ABOUT HUMIRA?
You should discuss the potential benefits and risks of HUMIRA with your doctor.
HUMIRA is a TNF blocker medicine that can lower the ability of your immune
system to fight infections. You should not start taking HUMIRA if you have any
kind of infection unless your doctor says it is okay.
* Serious infections have happened in people taking HUMIRA. These serious
infections include tuberculosis (TB) and infections caused by viruses, fungi,
or bacteria that have spread throughout the body. Some people have died from
these infections. Your doctor should test you for TB before starting HUMIRA,
and check you closely for signs and symptoms of TB during treatment with
HUMIRA, even if your TB test was negative. If your doctor feels you are at
risk, you may be treated with medicine for TB.
* Cancer. For children and adults taking TNF blockers, including HUMIRA, the
chance of getting lymphoma or other cancers may increase. There have been
cases of unusual cancers in children, teenagers, and young adults using TNF
blockers. Some people have developed a rare type of cancer called
hepatosplenic T-cell lymphoma. This type of cancer often results in death. If
using TNF blockers including HUMIRA, your chance of getting two types of skin
cancer (basal cell and squamous cell) may increase. These types are generally
not life-threatening if treated; tell your doctor if you have a bump or open
sore that doesn’t heal.
WHAT SHOULD I TELL MY DOCTOR BEFORE STARTING HUMIRA?
Tell your doctor about all of your health conditions, including if you:
* Have an infection, are being treated for infection, or have symptoms of an
infection
* Get a lot of infections or infections that keep coming back
* Have diabetes
* Have TB or have been in close contact with someone with TB, or were born in,
lived in, or traveled where there is more risk for getting TB
* Live or have lived in an area (such as the Ohio and Mississippi River
valleys) where there is an increased risk for getting certain kinds of fungal
infections, such as histoplasmosis, coccidioidomycosis, or blastomycosis.
These infections may happen or become more severe if you use HUMIRA. Ask your
doctor if you are unsure if you have lived in these areas
* Have or have had hepatitis B
* Are scheduled for major surgery
* Have or have had cancer
* Have numbness or tingling or a nervous system disease such as multiple
sclerosis or Guillain-Barré syndrome
* Have or had heart failure
* Have recently received or are scheduled to receive a vaccine. HUMIRA patients
may receive vaccines, except for live vaccines. Children should be brought up
to date on all vaccines before starting HUMIRA
* Are allergic to rubber, latex, or any HUMIRA ingredients
* Are pregnant, planning to become pregnant, breastfeeding, or planning to
breastfeed
* Have a baby and you were using HUMIRA during your pregnancy. Tell your baby’s
doctor before your baby receives any vaccines
Also tell your doctor about all the medicines you take. You should not take
HUMIRA with ORENCIA® (abatacept), KINERET® (anakinra), REMICADE® (infliximab),
ENBREL® (etanercept), CIMZIA® (certolizumab pegol), or SIMPONI® (golimumab).
Tell your doctor if you have ever used RITUXAN® (rituximab),
IMURAN® (azathioprine), or PURINETHOL® (mercaptopurine, 6-MP).
WHAT SHOULD I WATCH FOR AFTER STARTING HUMIRA?
HUMIRA can cause serious side effects, including:
* Serious infections. These include TB and infections caused by viruses, fungi,
or bacteria. Symptoms related to TB include a cough, low-grade fever, weight
loss, or loss of body fat and muscle.
* Hepatitis B infection in carriers of the virus. Symptoms include muscle
aches, feeling very tired, dark urine, skin or eyes that look yellow, little
or no appetite, vomiting, clay-colored bowel movements, fever, chills,
stomach discomfort, and skin rash.
* Allergic reactions. Symptoms of a serious allergic reaction include hives,
trouble breathing, and swelling of your face, eyes, lips, or mouth.
* Nervous system problems. Signs and symptoms include numbness or tingling,
problems with your vision, weakness in your arms or legs, and dizziness.
* Blood problems (decreased blood cells that help fight infections or stop
bleeding). Symptoms include a fever that does not go away, bruising or
bleeding very easily, or looking very pale.
* Heart failure (new or worsening). Symptoms include shortness of breath,
swelling of your ankles or feet, and sudden weight gain.
* Immune reactions including a lupus-like syndrome. Symptoms include chest
discomfort or pain that does not go away, shortness of breath, joint pain, or
rash on your cheeks or arms that gets worse in the sun.
* Liver problems. Symptoms include feeling very tired, skin or eyes that look
yellow, poor appetite or vomiting, and pain on the right side of your stomach
(abdomen). These problems can lead to liver failure and death.
* Psoriasis (new or worsening). Symptoms include red scaly patches or raised
bumps that are filled with pus.
Call your doctor or get medical care right away if you develop any of the above
symptoms.
Common side effects of HUMIRA include injection site reactions (pain, redness,
rash, swelling, itching, or bruising), upper respiratory infections (sinus
infections), headaches, rash, and nausea. These are not all of the possible side
effects with HUMIRA. Tell your doctor if you have any side effect that bothers
you or that does not go away.
REMEMBER, TELL YOUR DOCTOR RIGHT AWAY IF YOU HAVE AN INFECTION OR SYMPTOMS OF AN
INFECTION, INCLUDING:
* Fever, sweats, or chills
* Muscle aches
* Cough
* Shortness of breath
* Blood in phlegm
* Weight loss
* Warm, red, or painful skin or sores on your body
* Diarrhea or stomach pain
* Burning when you urinate
* Urinating more often than normal
* Feeling very tired
HUMIRA is given by injection under the skin.
This is the most important information to know about HUMIRA. For more
information, talk to your health care provider.
Uses
HUMIRA is a prescription medicine used:
* To reduce the signs and symptoms of:
* Moderate to severe rheumatoid arthritis (RA) in adults. HUMIRA can be used
alone, with methotrexate, or with certain other medicines. HUMIRA may
prevent further damage to your bones and joints and may help your ability
to perform daily activities.
* Moderate to severe polyarticular juvenile idiopathic arthritis (JIA) in
children 2 years of age and older. HUMIRA can be used alone or with
methotrexate.
* Psoriatic arthritis (PsA) in adults. HUMIRA can be used alone or with
certain other medicines. HUMIRA may prevent further damage to your bones
and joints and may help your ability to perform daily activities.
* Ankylosing spondylitis (AS) in adults.
* Moderate to severe hidradenitis suppurativa (HS) in people 12 years and
older.
* To treat moderate to severe Crohn’s disease (CD) in adults and children 6
years of age and older.
* To treat moderate to severe ulcerative colitis (UC) in adults and children 5
years of age and older. It is not known if HUMIRA is effective in people who
stopped responding to or could not tolerate anti-TNF medicines.
* To treat moderate to severe chronic plaque psoriasis (Ps) in adults who are
ready for systemic therapy or phototherapy, and are under the care of a
doctor who will decide if other systemic therapies are less appropriate.
* To treat non-infectious intermediate (middle part of the eye), posterior
(back of the eye), and panuveitis (all parts of the eye) in adults and
children 2 years of age and older.
US-HUM-210186
Please see the Full Prescribing Information, including the Medication Guide, for
HUMIRA.
You are encouraged to report negative side effects of prescription drugs to the
FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088.
If you are having difficulty paying for your medicine, AbbVie may be able to
help. Visit AbbVie.com/myAbbVieAssist to learn more.
Legal Notices/Privacy Policy. Copyright 2021, AbbVie Inc., North Chicago,
Illinois, U.S.A. If you have any questions about AbbVie’s HUMIRA.com website
that have not been answered click here. This website and the information
contained herein is intended for use by US residents only, is provided for
informational purposes only and is not intended to replace a discussion with a
healthcare provider. All decisions regarding patient care must be made with a
healthcare provider and consider the unique characteristics of each patient.
Reference: 1. HUMIRA Injection [package insert]. North Chicago, IL: AbbVie Inc.
CONDITIONS HUMIRA TREATS
* Moderate to Severe Rheumatoid Arthritis
* Moderate to Severe Chronic Plaque Psoriasis
* Moderate to Severe Crohn's Disease
* Moderate to Severe Pediatric Crohn's Disease
* Moderate to Severe Ulcerative Colitis
* Moderate to Severe Pediatric Ulcerative Colitis
* Psoriatic Arthritis
* Moderate to Severe Hidradenitis Suppurativa
* Ankylosing Spondylitis
* Moderate to Severe Polyarticular Juvenile Idiopathic Arthritis
* Non-Infectious Intermediate, Posterior, and Panuveitis
* About HUMIRA Complete
* Complete Resource Center
* Cost & Savings
IMPORTANT SAFETY INFORMATION FOR PATIENTS
* Important Safety Information
* Medication Guide
* Full Prescribing Information
* Información en Español
INFORMATION FROM ABBVIE
* Health Care Professional Site
* Accessibility Statement
* Contact Us
* Terms of Use
* Privacy Notice
* Cookies Settings
* Your Privacy Choices
--------------------------------------------------------------------------------
©2023 AbbVie. All rights reserved. HUMIRA® and its design are registered
trademarks of AbbVie Biotechnology Ltd.
US-HUM-220495
IMPORTANT SAFETY INFORMATION
ABOUT HUMIRA® (ADALIMUMAB)1
WHAT IS THE MOST IMPORTANT INFORMATION I SHOULD KNOW ABOUT HUMIRA?
You should discuss the potential benefits and risks of HUMIRA with your doctor.
HUMIRA is a TNF blocker medicine that can lower the ability of your immune
system to fight infections. You should not start taking HUMIRA if you have any
kind of infection unless your doctor says it is okay.
* Serious infections have happened in people taking HUMIRA. These serious
infections include tuberculosis (TB) and infections caused by viruses, fungi,
or bacteria that have spread throughout the body. Some people have died from
these infections. Your doctor should test you for TB before starting HUMIRA,
and check you closely for signs and symptoms of TB during treatment with
HUMIRA, even if your TB test was negative. If your doctor feels you are at
risk, you may be treated with medicine for TB.
* Cancer. For children and adults taking TNF blockers, including HUMIRA, the
chance of getting lymphoma or other cancers may increase. There have been
cases of unusual cancers in children, teenagers, and young adults using TNF
blockers. Some people have developed a rare type of cancer called
hepatosplenic T-cell lymphoma. This type of cancer often results in death. If
using TNF blockers including HUMIRA, your chance of getting two types of skin
cancer (basal cell and squamous cell) may increase. These types are generally
not life-threatening if treated; tell your doctor if you have a bump or open
sore that doesn’t heal.
WHAT SHOULD I TELL MY DOCTOR BEFORE STARTING HUMIRA?
Tell your doctor about all of your health conditions, including if you:
* Have an infection, are being treated for infection, or have symptoms of an
infection
* Get a lot of infections or infections that keep coming back
* Have diabetes
* Have TB or have been in close contact with someone with TB, or were born in,
lived in, or traveled where there is more risk for getting TB
* Live or have lived in an area (such as the Ohio and Mississippi River
valleys) where there is an increased risk for getting certain kinds of fungal
infections, such as histoplasmosis, coccidioidomycosis, or blastomycosis.
These infections may happen or become more severe if you use HUMIRA. Ask your
doctor if you are unsure if you have lived in these areas
* Have or have had hepatitis B
* Are scheduled for major surgery
* Have or have had cancer
* Have numbness or tingling or a nervous system disease such as multiple
sclerosis or Guillain-Barré syndrome
* Have or had heart failure
* Have recently received or are scheduled to receive a vaccine. HUMIRA patients
may receive vaccines, except for live vaccines. Children should be brought up
to date on all vaccines before starting HUMIRA
* Are allergic to rubber, latex, or any HUMIRA ingredients
* Are pregnant, planning to become pregnant, breastfeeding, or planning to
breastfeed
* Have a baby and you were using HUMIRA during your pregnancy. Tell your baby’s
doctor before your baby receives any vaccines
Also tell your doctor about all the medicines you take. You should not take
HUMIRA with ORENCIA® (abatacept), KINERET® (anakinra), REMICADE® (infliximab),
ENBREL® (etanercept), CIMZIA® (certolizumab pegol), or SIMPONI® (golimumab).
Tell your doctor if you have ever used RITUXAN® (rituximab),
IMURAN® (azathioprine), or PURINETHOL® (mercaptopurine, 6-MP).
WHAT SHOULD I WATCH FOR AFTER STARTING HUMIRA?
HUMIRA can cause serious side effects, including:
* Serious infections. These include TB and infections caused by viruses, fungi,
or bacteria. Symptoms related to TB include a cough, low-grade fever, weight
loss, or loss of body fat and muscle.
* Hepatitis B infection in carriers of the virus. Symptoms include muscle
aches, feeling very tired, dark urine, skin or eyes that look yellow, little
or no appetite, vomiting, clay-colored bowel movements, fever, chills,
stomach discomfort, and skin rash.
* Allergic reactions. Symptoms of a serious allergic reaction include hives,
trouble breathing, and swelling of your face, eyes, lips, or mouth.
* Nervous system problems. Signs and symptoms include numbness or tingling,
problems with your vision, weakness in your arms or legs, and dizziness.
* Blood problems (decreased blood cells that help fight infections or stop
bleeding). Symptoms include a fever that does not go away, bruising or
bleeding very easily, or looking very pale.
* Heart failure (new or worsening). Symptoms include shortness of breath,
swelling of your ankles or feet, and sudden weight gain.
* Immune reactions including a lupus-like syndrome. Symptoms include chest
discomfort or pain that does not go away, shortness of breath, joint pain, or
rash on your cheeks or arms that gets worse in the sun.
* Liver problems. Symptoms include feeling very tired, skin or eyes that look
yellow, poor appetite or vomiting, and pain on the right side of your stomach
(abdomen). These problems can lead to liver failure and death.
* Psoriasis (new or worsening). Symptoms include red scaly patches or raised
bumps that are filled with pus.
Call your doctor or get medical care right away if you develop any of the above
symptoms.
Common side effects of HUMIRA include injection site reactions (pain, redness,
rash, swelling, itching, or bruising), upper respiratory infections (sinus
infections), headaches, rash, and nausea. These are not all of the possible side
effects with HUMIRA. Tell your doctor if you have any side effect that bothers
you or that does not go away.
REMEMBER, TELL YOUR DOCTOR RIGHT AWAY IF YOU HAVE AN INFECTION OR SYMPTOMS OF AN
INFECTION, INCLUDING:
* Fever, sweats, or chills
* Muscle aches
* Cough
* Shortness of breath
* Blood in phlegm
* Weight loss
* Warm, red, or painful skin or sores on your body
* Diarrhea or stomach pain
* Burning when you urinate
* Urinating more often than normal
* Feeling very tired
HUMIRA is given by injection under the skin.
This is the most important information to know about HUMIRA. For more
information, talk to your health care provider.
Uses
HUMIRA is a prescription medicine used:
* To reduce the signs and symptoms of:
* Moderate to severe rheumatoid arthritis (RA) in adults. HUMIRA can be used
alone, with methotrexate, or with certain other medicines. HUMIRA may
prevent further damage to your bones and joints and may help your ability
to perform daily activities.
* Moderate to severe polyarticular juvenile idiopathic arthritis (JIA) in
children 2 years of age and older. HUMIRA can be used alone or with
methotrexate.
* Psoriatic arthritis (PsA) in adults. HUMIRA can be used alone or with
certain other medicines. HUMIRA may prevent further damage to your bones
and joints and may help your ability to perform daily activities.
* Ankylosing spondylitis (AS) in adults.
* Moderate to severe hidradenitis suppurativa (HS) in people 12 years and
older.
* To treat moderate to severe Crohn’s disease (CD) in adults and children 6
years of age and older.
* To treat moderate to severe ulcerative colitis (UC) in adults and children 5
years of age and older. It is not known if HUMIRA is effective in people who
stopped responding to or could not tolerate anti-TNF medicines.
* To treat moderate to severe chronic plaque psoriasis (Ps) in adults who are
ready for systemic therapy or phototherapy, and are under the care of a
doctor who will decide if other systemic therapies are less appropriate.
* To treat non-infectious intermediate (middle part of the eye), posterior
(back of the eye), and panuveitis (all parts of the eye) in adults and
children 2 years of age and older.
US-HUM-210186
LEAVING ABBVIE WEB SITE
You are leaving the AbbVie Web site and connecting to a site that is not under
the control of AbbVie. AbbVie is not responsible for the contents of any such
site or any further links from such site. AbbVie is providing these links to you
only as a convenience and the inclusion of any link does not imply the
endorsement of the linked site by AbbVie. You should also be aware that the
linked site may be governed by its own set of terms and conditions and privacy
policy for which AbbVie has no responsibility.
Conversely, the presence of this link does not imply the linked site's
endorsement of HUMIRA.com or AbbVie.
Do you wish to leave this site?
Yes
No
US-HUM-220495
LEAVING ABBVIE WEB SITE
You are leaving the AbbVie Web site and connecting to a site that is not under
the control of AbbVie. AbbVie is not responsible for the contents of any such
site or any further links from such site. AbbVie is providing these links to you
only as a convenience and the inclusion of any link does not imply the
endorsement of the linked site by AbbVie. You should also be aware that the
linked site may be governed by its own set of terms and conditions and privacy
policy for which AbbVie has no responsibility.
Conversely, the presence of this link does not imply the linked site's
endorsement of HUMIRA.com or AbbVie.
Do you wish to leave this site?
Yes
No
US-HUM-220495
LEAVING ABBVIE WEB SITE
You are leaving the AbbVie Web site and connecting to a site that is not under
the control of AbbVie. AbbVie is not responsible for the contents of any such
site or any further links from such site. AbbVie is providing these links to you
only as a convenience, and the inclusion of any link does not imply the
endorsement of the linked site by AbbVie. You should also be aware that the
linked site may be governed by its own set of terms and conditions and privacy
policy, for which AbbVie has no responsibility.
Conversely, the presence of this link does not imply the linked site's
endorsement of HUMIRA.com or AbbVie.
Do you wish to leave this site?
Yes
No
US-HUM-220495
LEAVING ABBVIE WEB SITE
You are leaving the AbbVie Web site and connecting to a site that is not under
the control of AbbVie. AbbVie is not responsible for the contents of any such
site or any further links from such site. AbbVie is providing these links to you
only as a convenience and the inclusion of any link does not imply the
endorsement of the linked site by AbbVie. You should also be aware that the
linked site may be governed by its own set of terms and conditions and privacy
policy for which AbbVie has no responsibility.
Conversely, the presence of this link does not imply the linked site's
endorsement of HUMIRA.com or AbbVie.
Do you wish to leave this site?
Yes
No
US-HUM-220495
CHOOSE YOUR CONDITION
Moderate to Severe
Rheumatoid Arthritis
Moderate to Severe Chronic
Plaque Psoriasis
Moderate to Severe
Crohn's Disease
Moderate to Severe
Pediatric Crohn's Disease
Moderate to Severe
Ulcerative Colitis
Moderate to Severe
Pediatric Ulcerative Colitis
Psoriatic Arthritis
Moderate to Severe
Hidradenitis Suppurativa
Ankylosing Spondylitis
Moderate to Severe Polyarticular
Juvenile Idiopathic Arthritis
Intermediate, Posterior, and Panuveitis
Non-Infectious Uveitis
LEAVING ABBVIE WEB SITE
You are leaving the AbbVie Web site and connecting to a site that is not under
the control of AbbVie. AbbVie is not responsible for the contents of any such
site or any further links from such site. AbbVie is providing these links to you
only as a convenience and the inclusion of any link does not imply the
endorsement of the linked site by AbbVie. You should also be aware that the
linked site may be governed by its own set of terms and conditions and privacy
policy for which AbbVie has no responsibility.
Conversely, the presence of this link does not imply the linked site's
endorsement of HUMIRA.com or AbbVie.
Do you wish to leave this site?
Yes
No
US-HUM-220495
LEAVING ABBVIE WEB SITE
You are leaving the AbbVie Web site and connecting to a site that is not under
the control of AbbVie. AbbVie is not responsible for the contents of any such
site or any further links from such site. AbbVie is providing these links to you
only as a convenience and the inclusion of any link does not imply the
endorsement of the linked site by AbbVie. You should also be aware that the
linked site may be governed by its own set of terms and conditions and privacy
policy for which AbbVie has no responsibility.
Conversely, the presence of this link does not imply the linked site's
endorsement of HUMIRA.com or AbbVie.
Do you wish to leave this site?
Yes
No
US-HUMG-230019
IMPORTANT SAFETY INFORMATION1
You should not start taking HUMIRA if you have any kind of infection unless your
doctor says it is okay. Serious infections have happened in people taking
HUMIRA. These serious infections include tuberculosis (TB) and infections caused
by viruses, fungi, or bacteria that have spread throughout the body. Some people
have died from these infections. Your doctor should test you for TB before
starting HUMIRA, and check you closely for signs and symptoms of TB during
treatment with HUMIRA, even if your TB test was negative. If your doctor feels
you are at risk, you may be treated with medicine for TB
IMPORTANT SAFETY INFORMATION1
You should not start taking HUMIRA if you have any kind of infection unless your
doctor says it is okay. Serious infections have happened in people taking
HUMIRA. These serious infections include tuberculosis (TB) and infections caused
by viruses, fungi, or bacteria that have spread throughout the body. Some people
have died from these infections. Your doctor should test you for TB before
starting HUMIRA, and check you closely for signs and symptoms of TB during
treatment with HUMIRA, even if your TB test was negative. If your doctor feels
you are at risk, you may be treated with medicine for TB
IMPORTANT SAFETY INFORMATION1
You should not start taking HUMIRA if you have any kind of infection unless your
doctor says it is okay. Serious infections have happened in people taking
HUMIRA. These serious infections include tuberculosis (TB) and infections caused
by viruses, fungi, or bacteria that have spread throughout the body. Some people
have died from these infections. Your doctor should test you for TB before
starting HUMIRA, and check you closely for signs and symptoms of TB during
treatment with HUMIRA, even if your TB test was negative. If your doctor feels
you are at risk, you may be treated with medicine for TB.
IMPORTANT SAFETY INFORMATION1
You should not start taking HUMIRA if you have any kind of infection unless your
doctor says it is okay. Serious infections have happened in people taking
HUMIRA. These serious infections include tuberculosis (TB) and infections caused
by viruses, fungi, or bacteria that have spread throughout the body. Some people
have died from these infections. Your doctor should test you for TB before
starting HUMIRA, and check you closely for signs and symptoms of TB during
treatment with HUMIRA, even if your TB test was negative. If your doctor feels
you are at risk, you may be treated with medicine for TB.
IMPORTANT SAFETY INFORMATION
ABOUT HUMIRA® (ADALIMUMAB)1
WHAT IS THE MOST IMPORTANT INFORMATION I SHOULD KNOW ABOUT HUMIRA?
You should discuss the potential benefits and risks of HUMIRA with your doctor.
HUMIRA is a TNF blocker medicine that can lower the ability of your immune
system to fight infections. You should not start taking HUMIRA if you have any
kind of infection unless your doctor says it is okay.
* Serious infections have happened in people taking HUMIRA. These serious
infections include tuberculosis (TB) and infections caused by viruses, fungi,
or bacteria that have spread throughout the body. Some people have died from
these infections. Your doctor should test you for TB before starting HUMIRA,
and check you closely for signs and symptoms of TB during treatment with
HUMIRA, even if your TB test was negative. If your doctor feels you are at
risk, you may be treated with medicine for TB.
* Cancer. For children and adults taking TNF blockers, including HUMIRA, the
chance of getting lymphoma or other cancers may increase. There have been
cases of unusual cancers in children, teenagers, and young adults using TNF
blockers. Some people have developed a rare type of cancer called
hepatosplenic T-cell lymphoma. This type of cancer often results in death. If
using TNF blockers including HUMIRA, your chance of getting two types of skin
cancer (basal cell and squamous cell) may increase. These types are generally
not life-threatening if treated; tell your doctor if you have a bump or open
sore that doesn’t heal.
WHAT SHOULD I TELL MY DOCTOR BEFORE STARTING HUMIRA?
Tell your doctor about all of your health conditions, including if you:
* Have an infection, are being treated for infection, or have symptoms of an
infection
* Get a lot of infections or infections that keep coming back
* Have diabetes
* Have TB or have been in close contact with someone with TB, or were born in,
lived in, or traveled where there is more risk for getting TB
* Live or have lived in an area (such as the Ohio and Mississippi River
valleys) where there is an increased risk for getting certain kinds of fungal
infections, such as histoplasmosis, coccidioidomycosis, or blastomycosis.
These infections may happen or become more severe if you use HUMIRA. Ask your
doctor if you are unsure if you have lived in these areas
* Have or have had hepatitis B
* Are scheduled for major surgery
* Have or have had cancer
* Have numbness or tingling or a nervous system disease such as multiple
sclerosis or Guillain-Barré syndrome
* Have or had heart failure
* Have recently received or are scheduled to receive a vaccine. HUMIRA patients
may receive vaccines, except for live vaccines. Children should be brought up
to date on all vaccines before starting HUMIRA
* Are allergic to rubber, latex, or any HUMIRA ingredients
* Are pregnant, planning to become pregnant, breastfeeding, or planning to
breastfeed
* Have a baby and you were using HUMIRA during your pregnancy. Tell your baby’s
doctor before your baby receives any vaccines
Also tell your doctor about all the medicines you take. You should not take
HUMIRA with ORENCIA® (abatacept), KINERET® (anakinra), REMICADE® (infliximab),
ENBREL® (etanercept), CIMZIA® (certolizumab pegol), or SIMPONI® (golimumab).
Tell your doctor if you have ever used RITUXAN® (rituximab),
IMURAN® (azathioprine), or PURINETHOL® (mercaptopurine, 6-MP).
WHAT SHOULD I WATCH FOR AFTER STARTING HUMIRA?
HUMIRA can cause serious side effects, including:
* Serious infections. These include TB and infections caused by viruses, fungi,
or bacteria. Symptoms related to TB include a cough, low-grade fever, weight
loss, or loss of body fat and muscle.
* Hepatitis B infection in carriers of the virus. Symptoms include muscle
aches, feeling very tired, dark urine, skin or eyes that look yellow, little
or no appetite, vomiting, clay-colored bowel movements, fever, chills,
stomach discomfort, and skin rash.
* Allergic reactions. Symptoms of a serious allergic reaction include hives,
trouble breathing, and swelling of your face, eyes, lips, or mouth.
* Nervous system problems. Signs and symptoms include numbness or tingling,
problems with your vision, weakness in your arms or legs, and dizziness.
* Blood problems (decreased blood cells that help fight infections or stop
bleeding). Symptoms include a fever that does not go away, bruising or
bleeding very easily, or looking very pale.
* Heart failure (new or worsening). Symptoms include shortness of breath,
swelling of your ankles or feet, and sudden weight gain.
* Immune reactions including a lupus-like syndrome. Symptoms include chest
discomfort or pain that does not go away, shortness of breath, joint pain, or
rash on your cheeks or arms that gets worse in the sun.
* Liver problems. Symptoms include feeling very tired, skin or eyes that look
yellow, poor appetite or vomiting, and pain on the right side of your stomach
(abdomen). These problems can lead to liver failure and death.
* Psoriasis (new or worsening). Symptoms include red scaly patches or raised
bumps that are filled with pus.
Call your doctor or get medical care right away if you develop any of the above
symptoms.
Common side effects of HUMIRA include injection site reactions (pain, redness,
rash, swelling, itching, or bruising), upper respiratory infections (sinus
infections), headaches, rash, and nausea. These are not all of the possible side
effects with HUMIRA. Tell your doctor if you have any side effect that bothers
you or that does not go away.
REMEMBER, TELL YOUR DOCTOR RIGHT AWAY IF YOU HAVE AN INFECTION OR SYMPTOMS OF AN
INFECTION, INCLUDING:
* Fever, sweats, or chills
* Muscle aches
* Cough
* Shortness of breath
* Blood in phlegm
* Weight loss
* Warm, red, or painful skin or sores on your body
* Diarrhea or stomach pain
* Burning when you urinate
* Urinating more often than normal
* Feeling very tired
HUMIRA is given by injection under the skin.
This is the most important information to know about HUMIRA. For more
information, talk to your health care provider.
Uses
HUMIRA is a prescription medicine used:
* To reduce the signs and symptoms of:
* Moderate to severe rheumatoid arthritis (RA) in adults. HUMIRA can be used
alone, with methotrexate, or with certain other medicines. HUMIRA may
prevent further damage to your bones and joints and may help your ability
to perform daily activities.
* Moderate to severe polyarticular juvenile idiopathic arthritis (JIA) in
children 2 years of age and older. HUMIRA can be used alone or with
methotrexate.
* Psoriatic arthritis (PsA) in adults. HUMIRA can be used alone or with
certain other medicines. HUMIRA may prevent further damage to your bones
and joints and may help your ability to perform daily activities.
* Ankylosing spondylitis (AS) in adults.
* Moderate to severe hidradenitis suppurativa (HS) in people 12 years and
older.
* To treat moderate to severe Crohn’s disease (CD) in adults and children 6
years of age and older.
* To treat moderate to severe ulcerative colitis (UC) in adults and children 5
years of age and older. It is not known if HUMIRA is effective in people who
stopped responding to or could not tolerate anti-TNF medicines.
* To treat moderate to severe chronic plaque psoriasis (Ps) in adults who are
ready for systemic therapy or phototherapy, and are under the care of a
doctor who will decide if other systemic therapies are less appropriate.
* To treat non-infectious intermediate (middle part of the eye), posterior
(back of the eye), and panuveitis (all parts of the eye) in adults and
children 2 years of age and older.
US-HUM-210186
This site uses online tracking technologies such as cookies to personalize
content, save your preferences, provide social media features, enable
personalized advertising and track the site’s performance as described in our
Privacy Notice. Please click on Cookies Settings below to manage your
preferences.
Cookies Settings
PRIVACY PREFERENCE CENTER
When you visit any website, it may store or retrieve information on your
browser, mostly in the form of cookies. This information might be about you,
your preferences or your device and is mostly used to make the site work as you
expect it to. The information does not usually directly identify you, but it can
give you a more personalized web experience.
You can choose not to allow some types of cookies. Click on the different
category headings to find out more and change our default settings. However,
blocking some types of cookies may impact your experience of the site and the
services we are able to offer.
More information
MANAGE CONSENT PREFERENCES
REQUIRED COOKIES
Always Active
These cookies are necessary for the website to function and cannot be switched
off in our systems. They may be set by us or by third party providers whose
services we have added to our pages. They are usually only set in response to
actions made by you which amount to a request for services, such as setting your
privacy preferences, logging in or filling in forms. You can set your browser to
block or alert you about these cookies, but some parts of the site will not then
work.
FUNCTIONAL COOKIES
Always Active
These cookies allow us to count visits and traffic sources so we can measure and
improve the performance of our site. They may be set by us or by third party
providers whose services we have added to our pages. They help us to know which
pages are the most and least popular and see how visitors move around the site.
ADVERTISING COOKIES
Advertising Cookies
These cookies may be set through our site by our advertising partners to build a
profile of your interests and show you relevant adverts on other sites. They do
not store directly personal information but are based on uniquely identifying
your browser and internet device. If you do not allow these cookies, you will
experience less targeted advertising, but you will still receive online
advertising.
Back Button
PERFORMANCE COOKIES
Search Icon
Filter Icon
Clear
checkbox label label
Apply Cancel
Consent Leg.Interest
checkbox label label
checkbox label label
checkbox label label
Confirm My Choices